Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Notch receptor is a single-pass transmembrane protein that plays a central role in the Notch signaling pathway, regulating cell fate decisions during development and maintaining tissue homeostasis. In mammals, there are four distinct Notch receptors: NOTCH1, NOTCH2, NOTCH3, and NOTCH4. Activation occurs via juxtacrine signaling with ligands like Delta-like and Jagged proteins, leading to proteolytic cleavages and release of NICD, which regulates gene expression. Dysregulation or mutation of Notch receptors is implicated in various diseases, including cancer and developmental disorders.
Inhibition of Notch signaling pathway by preventing S2 or S3 cleavage, thereby blocking NICD release and downstream transcriptional activation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notch Receptor (Notch).